Lineage Cell Therapeutics (LCTX) Earnings
|
Expand Research on LCTX
| Next EPS Date | 11/5/26 | EPS Growth Rate | +76.9% |
|---|---|---|---|
| Average EPS % Beat Rate | -283.3% | Revenue Growth Rate | -30.7% |
| Average % Move 1-Wk after EPS | +2.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | -$0.03 | N/A | N/A | $2.55M | N/A | N/A | N/A | ||
| 8/6/26 | Q226 | -$0.03 | -$0.02 | -$0.01 | $1.07M | $4.57M | N/A |  | | Details | |
| 5/12/26 | Q126 | -$0.03 | -$0.01 | -$0.02 | $1.73M | $3.43M | N/A | | | Details | |
| 3/5/26 |
Q425 | N/A | -$0.05 | N/A | N/A | $1.96M | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | -$0.13 | -$0.02 | -$0.11 | $3.68M | $2.3M | N/A | | | Details | |
| 8/12/25 | Q225 | -$0.13 | -$0.03 | -$0.10 | $2.77M | $1.48M | N/A | | | Details | |
| 5/13/25 | Q125 | -$0.02 | -$0.03 | +$0.01 | $1.5M | $2.01M | N/A | | | Details | |
| 3/10/25 | Q424 | $0.02 | $0.00 | +$0.02 | $2.9M | N/A | N/A | | | Details |
